Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
70
TAK Quote, Financials, Valuation and Earnings
Last price:
$15.58
Seasonality move
:
4.51%
Day range:
$15.52 - $15.62
52-week range:
$12.80 - $15.69
Dividend yield:
4.24%
P/E ratio:
197.72x
P/S ratio:
1.68x
P/B ratio:
1.02x
Volume:
1.3M
Avg. volume:
2.9M
1-year change:
18.3%
Market cap:
$49.2B
Revenue:
$30.1B
EPS (TTM):
$0.08
Earnings Data
Next earnings date for TAK
Jan 29
2026
Most recent earnings per share
-$0.03
Missed by $0.03
(Oct 30/2025)
Consensus Estimate
--
(Oct 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TAK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/29/2026 | Q4 | $7.8B | -- | -- | -- | -- |
| 10/30/2025 | Q3 | $7.8B | $7.5B | -$0.03 | -- | -- |
| 07/30/2025 | Q2 | $7.9B | $7.7B | $0.27 | -- | -- |
| 05/08/2025 | Q1 | $7.6B | $6.9B | -$0.21 | -- | -- |
| 01/30/2025 | Q4 | $7.3B | $7.5B | $0.05 | -- | -- |
| 10/31/2024 | Q3 | $7.2B | $7.9B | $0.19 | -- | -- |
| 07/31/2024 | Q2 | $6.8B | $7.8B | $0.19 | -- | -- |
| 05/09/2024 | Q1 | $5.8B | $7.1B | -$0.01 | -- | -- |
| 02/01/2024 | Q4 | $6.8B | $7.5B | $0.23 | -- | -- |
| 10/26/2023 | Q3 | -- | $7.2B | -$0.11 | -- | -- |
| 07/27/2023 | Q2 | -- | $7.7B | $0.21 | -- | -- |
| 05/11/2023 | Q1 | -- | $7.2B | $0.07 | -- | -- |
| 02/02/2023 | Q4 | -- | $7.8B | $0.27 | -- | -- |
| 10/27/2022 | Q3 | -- | $7.2B | $0.14 | -- | -- |
| 07/28/2022 | Q2 | -- | $7.5B | $0.26 | -- | -- |
| 05/11/2022 | Q1 | -- | $7.5B | -$0.03 | -- | -- |
| 02/03/2022 | Q4 | -- | $7.9B | $0.16 | -- | -- |
| 10/28/2021 | Q3 | -- | $7.7B | $0.13 | -- | -- |
| 07/30/2021 | Q2 | -- | $8.7B | $0.40 | -- | -- |
| 05/11/2021 | Q1 | -- | $7.3B | $0.59 | -- | -- |
| 02/04/2021 | Q4 | -- | $8B | $0.28 | -- | -- |
| 10/29/2020 | Q3 | -- | $7.4B | $0.01 | -- | -- |
| 07/31/2020 | Q2 | -- | $7.5B | $0.25 | -- | -- |
| 03/31/2020 | Q1 | -- | $7.1B | $0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | $7.9B | -$0.10 | -- | -- |
| 09/30/2019 | Q3 | -- | $7.6B | $0.20 | -- | -- |
| 06/30/2019 | Q2 | -- | $7.7B | $0.02 | -- | -- |
| 03/31/2019 | Q1 | -- | $6.5B | -$0.09 | -- | -- |
| 12/31/2018 | Q4 | -- | $4.4B | $0.21 | -- | -- |
| 09/30/2018 | Q3 | -- | $3.9B | $0.28 | -- | -- |
| 06/30/2018 | Q2 | -- | $4.1B | $0.46 | -- | -- |
| 03/31/2018 | Q1 | -- | $3.7B | -$0.32 | -- | -- |
| 12/31/2017 | Q4 | -- | $4.3B | $0.38 | -- | -- |
| 09/30/2017 | Q3 | -- | $3.9B | $0.16 | -- | -- |
| 06/30/2017 | Q2 | -- | $4B | $0.83 | -- | -- |
| 03/31/2017 | Q1 | -- | $3.7B | -$0.29 | -- | -- |
| 12/31/2016 | Q4 | -- | $4.2B | $0.24 | -- | -- |
| 09/30/2016 | Q3 | -- | $4.1B | $0.15 | -- | -- |
| 06/30/2016 | Q2 | -- | $4B | $0.59 | -- | -- |
| 03/31/2016 | Q1 | -- | $3.6B | -$0.19 | -- | -- |
| 12/31/2015 | Q4 | -- | $4B | $0.31 | -- | -- |
Takeda Pharmaceutical Co., Ltd. Earnings Questions
-
How Much did Takeda Pharmaceutical Co., Ltd. Generate in Revenue Last Quarter?
Takeda Pharmaceutical Co., Ltd. reported $7.5B worth of top line sales in its most recent quarter.
-
Did Takeda Pharmaceutical Co., Ltd. Beat Earnings Last Quarter?
Takeda Pharmaceutical Co., Ltd. announced earnings per share of -$0.03 which represents a miss of analyst forecast a -- per share.
-
Is Takeda Pharmaceutical Co., Ltd. Profitable?
Takeda Pharmaceutical Co., Ltd. reported $3.6B that represents $1.13 per share over the last quarter.
-
What is the Analyst Consensus for Takeda Pharmaceutical Co., Ltd. EPS Next Year?
Takeda Pharmaceutical Co., Ltd.'s earnings are forecast to grow from $0.22 per share to -- per share next year representing an increase of --.
-
When is Takeda Pharmaceutical Co., Ltd.'s Earnings Date?
Takeda Pharmaceutical Co., Ltd.'s next earnings date is January 29, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
